GIA
RVMD icon

GHP Investment Advisors’s Revolution Medicines RVMD Stock Holding History

GHP Investment Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188 Hold
1
– – ﹤0.01% 1192
2026
Q1 		$98 Buy
+1
New +$101 ﹤0.01% 1305

Other funds holding RVMD

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

GHP Investment Advisors's RVMD Position: Q2 2026 in Review

GHP Investment Advisors held its Revolution Medicines (RVMD) position steady in Q2 2026 at 1 share worth $188. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

GHP Investment Advisors first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 199 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • GHP Investment Advisors held 1 share of Revolution Medicines worth $188 as of Q2 2026.
  • GHP Investment Advisors left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1192 holding.
  • GHP Investment Advisors first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 199 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.